Large-scale testing (Phase 3)Not Yet RecruitingNCT07823491
What this trial is testing
Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall
Who this might be right for
Resectable LiposarcomaResectable Soft Tissue SarcomaResectable Undifferentiated Pleomorphic Sarcoma
Ohio State University Comprehensive Cancer Center 228